Related references
Note: Only part of the references are listed.Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial
Ivalina Hristova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom
John J. Sunderland et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Performance evaluation of the Biograph mCT Flow PET/CT system according to the NEMA NU2-2012 standard
Ivo Rausch et al.
EJNMMI PHYSICS (2015)
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures
Nikolaos E. Makris et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
Charline Lasnon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Prognostic value of metabolic tumor burden on F-18-FDG PET in nonsurgical patients with non-small cell lung cancer
Shengri Liao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Mutatis Mutandis: Harmonize the Standard!
Ronald Boellaard
JOURNAL OF NUCLEAR MEDICINE (2012)
18F-FDG PET as a Surrogate Biomarker in Non Small Cell Lung Cancer Treated with Erlotinib: Newly Identified Lesions Are More Informative Than Standardized Uptake Value
Thomas Bengtsson et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer
Wei Huang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
Tejpal Gupta et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start
Andrew J. Buckler et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Variations in PET/CT Methodology for Oncologic Imaging at US Academic Medical Centers: An Imaging Response Assessment Team Survey
Michael M. Graham et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users
Thomas Beyer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
SUVref: reducing reconstruction-dependent variation in PET SUV
Matthew D. Kelly et al.
EJNMMI RESEARCH (2011)
A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
Michael C. Adams et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Revisiting the prognostic value of preoperative 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC)
Mohit Agarwal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The role of 18F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours
Bernadette G. Dijkman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy
Paul E. Kinahan et al.
SEMINARS IN ULTRASOUND CT AND MRI (2010)
Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
Rodney J. Hicks
JOURNAL OF NUCLEAR MEDICINE (2009)
Standards for PET Image Acquisition and Quantitative Data Analysis
Ronald Boellaard
JOURNAL OF NUCLEAR MEDICINE (2009)
Qualification of PET Scanners for Use in Multicenter Cancer Clinical Trials: The American College of Radiology Imaging Network Experience
Joshua S. Scheuermann et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Assessing Tumor Response to Therapy
Wolfgang A. Weber
JOURNAL OF NUCLEAR MEDICINE (2009)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer:: A systematic review
Yee C. Ung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
18F-FDG PET for mediastinal staging of lung cancer:: Which SUV threshold makes sense?
Dirk Hellwig et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer - A systematic review
Lioe-Fee de Geus-Oei et al.
CANCER (2007)
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
Susanne Martina Eschmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use
WA Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Clinical biomarkers in drug discovery and development
R Frank et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
